The AIM of this experimental study was to evaluate the effect of the antioxidant drug "U-74389G" in a rat model of hypoxia reoxygenation (HR) using the previously established protocol. Effects of treatment were evaluated by mean red blood cell distribution width (RDW) levels. MATERIALS AND METHODS: 40 rats of a mean weight of 231.875 g were employed in the study. RDW levels were determined at 60 min (groups A and C) and at 120 min (groups B and D) after starting the reoxygenation. Groups A and B received no drugs, whereas rats from groups C and D were administered with U-74389G. RESULTS: demonstrated that U-74389G administration signifi cantly decreased the RDW levels by 4.96% + 2.27% (p = 0.0175). Reoxygenation time non-signifi cantly decreased the RDW levels by 0.27% + 2.41% (p = 0.8889). Together, U-74389G administration and reoxygenation time nonsignifi cantly decreased the RDW levels by 2.54% + 1.39% (p = 0.0679). CONCLUSIONS: U-74389G administration particulary in concert without reperfusion declines the RDW levels even within the short -time context of 1.5 hours reperfusion.
INTRODUCTION
One of the main causes of permanent or transient damage with serious implications on adjacent organs and systems is tissue ischemia and reperfusion (IR). The use of U-74389G in IR has been a challenge for many years. However, although the progress was signifi cant, several practical questions have not been clarifi ed. They include: a) how potent U-74389G should be b) when it should be administered and c) in which optimal dose U-74389G should be administered. The promising effect of U-74389G in tissue protection has been noted in several IR studies. U-74389G, or also known as 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-pregna-1,4,9(11)-triene-3,20-dione maleate salt, is an antioxidant which prevents both arachidonic acid-induced and iron-dependent lipid peroxidation. 1 It protects against IR injury in animal heart, liver and kidney models. These membrane-associating antioxidants are particularly effective in preventing permeability changes in brain microvascular endothelial cells monolayers. 2 Lazaroids, a novel series of glucocorticoid compounds 21-aminosteroids, have the properties of free radical scavenging. U-74389G is one of the 132 similar lazaroid compounds. It has a molecular weight of 726.90406 g/mol; it has a selective action on vascular endothelium with vitamin E-like properties. The most famous activity is that of neuroprotective and membrane-stabilizing properties. Although it accumulates in the cell membrane thus protecting vascular endothelium from peroxidative damage, it hardly penetrates the blood-brain barrier. More specifi cally, Hori H et al. 3 showed its excellent effect on central nervous system trauma and ischemia. The degree of elevation of action potential thresholds and the rate of missing outer hair cells were signifi cantly reduced demonstrating that U-74389G has a protective effect on cisplatininduced ototoxicity without glucocorticoid action. Schmid-Elsaesser R et al. 4 showed signifi cantly less neurologic defi cits postoperatively and signifi cantly reduced cortical infarct volumes by the neuroprotective microvascularly acting 21-aminosteroid U-74389G. Passaquin AC et al. 5 elicited a benefi cial effect of glucocorticoids in Duchenne muscular dystrophy, attributing it to a reduction of the pathological increase in Ca + + infl ux via an effect on the sarcolemma of C2C12 skeletal muscle cells. Van Table 1 . The U-74389G infl uence (± SD) on the levels of some seric variables 15 Klaveren Rj et al. 6 supposed that direct inactivation of the membrane-bound γGT by hyperoxia is the most likely mechanism for the increased γGT, SOD, and GSH levels in oxygen-exposed cells by U-74389G. Schmid-Elsaesser R et al. 7 concluded that antioxidative compounds which cross the blood-brain barrier are more effective in focal cerebral ischemia than agents which predominantly act on the endothelium of cerebral microvessels. Lehmann C et al. 8 13 showed antiproliferative properties on cancer cells calculating an IC50 value at 91 m mM. Kondziolka D et al. 14 prevented regional edema favoring radiosurgery, surrounding brain protection without reducing the desired therapeutic effect. A meta-analysis of 13 published seric variables coming from the same experimental setting, tried to provide a numeric evaluation of the U-74389G effi cacy at the same endpoints (Table 1) . Several publications addressed trials of other similar antioxidant molecules to which the studied molecule U-74389G belongs.
AIM
The aim of this experimental study was to evaluate the effect of U-74389G in a rat model of hypoxia -reoxygenation (HR) using mean red blood cell distribution width (RDW) levels. Inc. S.A. at Pikermi, Attiki. Accepted standards of humane animal care were adopted for Albino female Wistar rats. Normal housing included continuous access to food and water in laboratory 7 days before the experiment. The experiment was acute, this is, awakening and preservation of animals was not following the experiment. Rats were randomly delivered to four experimental groups by 10 animals in each one, using following protocols of HR: hypoxia for 45 min followed by reoxygenation for 60 min (group A); hypoxia for 45 min followed by reoxygenation for 120 min (group B); hypoxia for 45 min followed by immediate U-74389G intravenous (IV) administration and reoxygenation for 60 min (group C); hypoxia for 45 min followed by immediate U-74389G IV administration and reoxygenation for 120 min (group D). The dose of U-74389G was 10 mg/kg body mass of animals. Prenarcosis preceded general anesthesia. The detailed anesthesiologic technique is described in related references. [15] [16] [17] Oxygen supply, electrocardiogram and acidometry were continuously provided during whole experiment performance. The protocol of HR was followed. Hypoxia was caused by clamping inferior aorta over renal arteries with forceps for 45 min after laparotomic access had been achieved. Reoxygenation was induced by removing the clamp and reestablishment of inferior aorta patency. After exclusion of a blood fl ow, the protocol of HR was applied as described above for each experimental group. U-74389G was administered at the time of reoxygenation; through inferior vena cava after the catheterization had been achieved. The RDW levels were determined at 60th min of reoxygenation (for A and C groups) and at 120th min of reoxygenation (for B and D groups Table 2) .
MATERIALS AND METHODS

ANIMAL
Lazaroid (L) group 20 L rats (mean mass 211.25 g [Std. Dev: 17.53755 g] suffered hypoxemia for 45 min followed by reoxygenation in the beginning of which 10 mg U-74389G/kg body weight were IV administered.
Group C Reoxygenation lasted for 60 min (n = 10 L Table 2) .
RESULTS
Rats of each group were compared by weight and RDW level with each other by statistical paired t-tests (Table 3) . Any signifi cant difference among RDW levels was investigated whether owed in potent signifi cant weight correlations. Applying generalized linear models (glm) with dependant variable the RDW levels and independent variables the U-74389G or no drug, the reperfusion time and both variables in combination resulted in following: U-74389G administration possessed a trend to signifi cantly decrease the RDW levels by 0.55% [-1.044414% --0.0555861%] (P = 0.0302). Table  3 are summed in Tables 4 and 5 . Considering the masses of the animals as independent variable at glm, a non-signifi cant association with RDW levels was revealed (p = 0.3928), suggesting that further investigation was not needed.
DISCUSSION
Salvagno GL et al 18 describe red blood cell distribution width (RDW) as a simple and inexpensive parameter, which refl ects the degree of heterogeneity of erythrocyte volume (conventionally known as anisocytosis); which is traditionally used in laboratory hematology for differential diagnosis of anemias. Nonetheless, recent evidence attests that anisocytosis is commonplace in human disorders such as cardiovascular disease, venous thromboembolism, cancer, diabetes, community-acquired pneumonia, chronic obstructive pulmonary disease, liver and kidney failure, as well as in other acute or chronic conditions. Even more importantly, the value of RDW is now being regarded as a strong and independent risk factor for death in the general population. An increased RDW mirrors a profound deregulation of erythrocyte homeostasis involving both impaired erythropoiesis and abnormal red blood cell survival, which may be attributed to a variety of underlying metabolic abnormalities such as shortening of telomere length, oxidative stress, infl ammation, poor nutritional status, dyslipidemia, hypertension, erythrocyte fragmentation and alteration of erythropoietin function.
The following situations show how hypoxia can infl uence RDW levels. Shrestha K et al 19 noticed neutrophil gelatinase-associated lipocalin (NGAL), an iron-regulatory glycoprotein, to be upregulated systemically in response to ischemia. Plasma NGAL levels were inversely correlated with indices of anemia including RDW levels (P =.007) independent of underlying oxidant stress and estimated myeloperoxidase levels (P =.045). Isik T et al. 20 have shown RDW levels as an independent correlate predictor index of adverse outcomes also associated with both presence and severity of isolated ischemia than baseline RDW levels measured at ischemic patients and controls. Sharp J et al. 21 considered mitochondrial dysfunction as a fundamental abnormality in the vascular endothelium and smooth muscle of patients with pulmonary arterial hypertension (PAH). Coenzyme Q (CoQ) is essential for mitochondrial function and effi cient oxygen utilization as the electron carrier in the inner mitochondrial membrane. PAH patients had higher CoQ levels than controls with supplementation, and a tendency to a higher reduced-tooxidized CoQ ratio. Cardiac parameters, hemoglobin and red cell maturation were improved and red cell distribution width (RDW) was decreased in PAH patients with CoQ supplementation, consistent with improved mitochondrial synthetic function. Bujak K et al. 22 included coronary artery disease (CAD) in the importance of RDW as a predictor of poor clinical outcomes in the settings of various diseases. The negative prognostic effects of elevated RDW levels may be attributed to the adverse effects of independent risk factors such as inflammation, oxidative stress, and vitamin D 3 and iron deficiency on bone marrow function (erythropoiesis). Elevated RDW values may refl ect the intensity of these phenomena and their unfavorable impacts on bone marrow erythropoiesis. Furthermore, decreased red blood cell deformability among patients with higher RDW values impairs blood fl ow through the microcirculation, resulting in the diminution of oxygen supply at the tissue level, particularly among patients suffering from myocardial infarction. Malik A et al 23 named eryptosis in analogy to apoptosis, the suicidal death of erythrocytes which involves cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Triggers of eryptosis include oxidative stress, increase of cytosolic Ca + + activity ([Ca + + ] i ), and ceramide. Phospholipid scrambling of the erythrocyte cell membrane is stimulated at least partially by the induction of oxidative stress, increase of [Ca + + ] i and up-regulation of 24 proposed chronic infl ammation as a candidate mechanism between benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS). MetS was diagnosed in 34% of BPH patients. The RDW values were found to be higher in the BPH group than in the control group by 0.7 ± 0.8 [P < 0.001]. There was a signifi cant correlation between RDW and total prostate volume (TPV) (r = 0.370, P < 0.001), body mass index (BMI) (r = 0.367, P < 0.001) and MetS (r = 0.276, P < 0.001).
The RDW level is signifi cantly higher in patients with BPH than that in control and independent predictor of MetS in BPH patients. Yilmaz Ö et al. 25 associated high levels of RDW with oxidative stress and cardiovascular disease risk. RDW levels were signifi cantly higher in the polycystic ovary syndrome (PCOS) group than in control group by 0.39 ± 0.88% (p = 0.004). RDW levels were positively correlated with hs-CRP, HOMA-IR and BMI. RDW levels were useful as a diagnostic marker for PCOS, fi nding an optimal cut-off value for detecting PCOS was ≥12.54% (sensitivity 67% and specifi city 70%). Subjects above this cut-off value were nearly 2.8 times more likely to develop PCOS than subjects under it. This link between RDW and PCOS may be due to an underlying chronic infl ammation in subjects with PCOS. Dada OA et al. 26 considered chronic infl ammation and increased levels of oxidative stress as telltale signs of type 2 diabetics. The mean RDW ± SD was higher in the diabetics by 0.4 ± 3.91 fl than in the controls. The mean RDW-CV (RDW coeffi cient of variation) was 0.06 + 1.32% for diabetics, higher than in controls fi nding a statistically signifi cant positive correlation between the RDW-CV and blood pressure in the diabetics. Lorente L et al. 27 found higher values of red blood cell distribution width (RDW) in non-surviving than in surviving septic patients. RDW predicted and was associated with 30-day mortality at the fi rst 8 days (p = 0.03). RDW showed a positive correlation with serum MDA levels until day 4, with serum TNF-α levels and SOFA score until day 8. Non-surviving septic patients showed persistently higher RDW during the fi rst week of ICU stay than survivors. RDW during the fi rst week was associated with sepsis severity and mortality; it could also be used as biomarker of outcome in septic patients. Tosu AR et al. 28 found that increased RDW levels are signifi cantly higher in non-dipper HT hypertension (NDHT) patients than dipper HT patients and control group (p < 0.05). Tsuboi S et al. 29 31 claim that exercise may enhance oxidative stress. Antioxidants can effi ciently scavenge ROS before they initiate oxidative damage of biomolecules such as enzymes, nucleic acids, lipids and lipoproteins in the body. The cholesterol and low density lipoprotein-cholesterol (LDL-C), red blood cell distribution width (RDW) and TBARS levels were signifi cantly decreased (P < 0.05) with exercise plus vitamin C. There were signifi cant correlations (P < 0.05 to P < 0.01) between lipid values and erythrocyte indices. In addition, exercise plus vitamin C may diminish TBARS-levels and may affect the values of RDW in young soccer players. Ribeiro IF et al. 32 investigated the infl uence of erythropoietin (EPO T→G) and α-actinin-3 (ACTN3 R577X) polymorphisms on plasma lipid peroxidation and hemogram. Both polymorphisms infl uenced the runners' response to pequi oil: signifi cant responses were observed for the EPO TT and TG genotypes in red blood cell distribution width values. These results emphasize the importance of studying nutrigenomic effects on athletes' performance. Prasad K considers 33 that hypercholesterolemia induces oxidative stress, which is known to have adverse effects on the integrity of cells. Hence, hypercholesterolemia may have adverse effects on the hemopoietic system. The results show that hypercholesterolemia increased RDW levels.
The assumption is whether U-74389G among and besides its above mentioned protective context on ototoxicity and central nervous system; in Duchenne muscular dystrophy; at inactivation of membranebound enzymes; on septic states; on endotoxemia; on learning impairments and at antiproliferative properties, has any possible effects also on acute hemopoiesis. The results of this study are very encouraging concerning RDW. There appears a current undiminished interest in the identifi cation of such a capacity that could urgently decline the RDW levels providing a beneficial decline for negative prognostic prospect in internal medicine.
CONCLUSIONS
U-74389G administration and particularly its interaction with reperfusion time signifi cantly declines the RDW levels favoring the prognostic effect in internal medicine.
